Simplified Chinese
The acceptance meeting for the 23-valent pneumococcal polysaccharide vaccine industrialization project was successfully held.
Release date:
2020-10-26
Author:
Source:
Abstract
On October 19, 2020, the project undertaken by Beijing Minhai Biotechnology Co., Ltd. under the National Development and Reform Commission’s 2014 program… Annual Special Project for the Development of Protein-Based Biologics and Vaccines – “23” An acceptance meeting for the “Industrialization of Pneumococcal Polysaccharide Vaccine (Bulk Production and Fill‑and‑Finish)” project was held under the auspices of the Beijing Municipal Development and Reform Commission. The meeting was attended by more than 15 participants, including representatives from the Beijing Municipal Development and Reform Commission, the Beijing Center for Disease Control and Prevention, technical and financial review experts, and the project leader. Following a project presentation, document review, expert questioning and clarification, and an on-site inspection of the production facility, the expert panel unanimously concluded that the project had successfully achieved all its planned objectives, met the acceptance criteria, and recommended approval of the project’s completion.

Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09